Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

RENB

Renovaro Biosciences Inc

Nov 28 • 02:59PM ET

3.18

Dollar change -0.25
Percentage change -7.22	%

Healthcare • Biotechnology • USA • NASD

Stock Detail • Compare Perf. • Options Chain • Save to Portfolio • Create Alert

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.66	Insider Own	56.29%	Shs Outstand	63.70M	Perf Week	10.12%
Market Cap	212.27M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	29.15M	Perf Month	17.43%
Income	-41.16M	PEG	-	EPS next Q	-	Inst Own	2.23%	Short Float / Ratio	2.19% / 2.97	Perf Quarter	22.40%
Sales	0.00M	P/S	-	EPS this Y	-	Inst Trans	-3.67%	Short Interest	0.64M	Perf Half Y	237.12%
Book/sh	0.71	P/B	4.47	EPS next Y	-	ROA	-58.53%	Target Price	-	Perf Year	80.82%
Cash/sh	0.01	P/C	408.20	EPS next 5Y	-	ROE	-70.32%	52W Range	0.39 - 5.25	Perf YTD	208.97%
Dividend	-	P/FCF	-	EPS past 5Y	-19.64%	ROI	-86.71%	52W High	-39.38%	Beta	0.32
Dividend %	-	Quick Ratio	0.19	Sales past 5Y	0.00%	Gross Margin	-	52W Low	710.18%	ATR	0.38
Employees	12	Current Ratio	0.19	Sales Q/Q	-	Oper. Margin	0.00%	RSI (14)	51.15	Volatility	12.79% 11.60%
Optionable	Yes	Debt/Eq	0.10	EPS Q/Q	-1.86%	Profit Margin	-	Rel Volume	0.31	Prev Close	3.43
Shortable	Yes	LT Debt/Eq	0.02	Earnings	-	Payout	-	Avg Volume	215.01K	Price	3.18
Recom	-	SMA20	7.12%	SMA50	-9.45%	SMA200	79.62%	Volume	56,987	Change	-7.22%

Nov-23-23 09:30AM	Renovaro BioSciences Poised to Spearhead Advancements in Battle Against Diseases (NewMediaWire)
Nov-22-23 10:44AM	Renovaro Biosciences CEO unveils potential breakthrough therapies and AI partnerships for 2024 (News Direct)
Nov-21-23 08:30AM	Renovaro BioSciences Eyes Opportunity in Precision Medicine Market (NewMediaWire)
Nov-14-23 09:00AM	Renovaro Biosciences CEO Provides Update on Combination with GEDiCube (NewMediaWire)
Nov-10-23 08:30AM	Renovaro BioSciences, GEDi Cube Combine to Transform Medicine Through AI, Biotherapeutics (NewMediaWire) +5.38%
08:30AM	Loading…
Nov-07-23 08:30AM	Renovaro Biosciences Adds Three New Members to Board as Definitive Agreement with GEDiCube Announced (NewMediaWire)
Oct-24-23 09:00AM	Renovaro BioSciences CEO Provides Insights on Agreement to Combine with GEDi Cube (NewMediaWire) -7.61%
Oct-11-23 09:25AM	Avram Miller, Co-Founder of Intel Capital, Joins Renovaro Biosciences Board of Directors (GlobeNewswire) -5.89%
08:30AM	Renovaro BioSciences Announces Board Appointments of Two Finance Experts (NewMediaWire)
Oct-10-23 08:00AM	Renovaro Biosciences Appoints Two Finance Industry Experts to Board of Directors (GlobeNewswire) +19.08%
Oct-04-23 09:00AM	Renovaro BioSciences CEO Releases Shareholder Letter (NewMediaWire)
Oct-02-23 12:05PM	Message from Renovaro Biosciences CEO, The Hon. Mark Dybul, MD (GlobeNewswire) +5.15%
09:25AM	AI Company GEDiCube and Renovaro Biosciences Sign Definitive Agreement to Combine (GlobeNewswire)
08:30AM	Renovaro BioSciences Enters Definitive Agreement to Combine with Leading AI Tech GEDi Cube (NewMediaWire)
Sep-29-23 09:15AM	Renovaro Biosciences and AI Health Company GEDi Cube Sign Definitive Agreement to Combine (GlobeNewswire) +9.83%
09:15AM	Loading…
09:15AM	GEDi Cube and Renovaro Biosciences Sign Definitive Agreement to Combine (Business Wire)
Sep-21-23 03:00PM	Renovaro BioSciences Targets Pancreatic Cancer Through Work With GEDI Cube AI Platform, NVIDIA Resources (NewMediaWire) +13.57%
Sep-19-23 08:30AM	Why Renovaro BioSciences Inc. Is 'One to Watch' (NewMediaWire)
Sep-06-23 12:40AM	Renovaro BioSciences Congratulates GEDiCube on New Joint Effort Clinical Trials (NewMediaWire) -6.98%
Aug-30-23 09:15AM	Renovaro BioSciences Welcomes GEDiCube Announcement of New Joint Effort (GlobeNewswire) +13.08%
Aug-21-23 09:15AM	Renovaro BioSciences Congratulates GEDi Cube on Appointment of its Chief Medical Officer (GlobeNewswire) +7.78%
Aug-10-23 12:06AM	Renovaro BioSciences, GEDi Cube Announce LOI to Merge, Focus on Fight Against Cancer (NewMediaWire)
Aug-09-23 09:00AM	AI Company GEDi Cube and Renovaro Biosciences Announce a Binding, Exclusive Letter of Intent to Merge, Accelerating Fight Against Cancer (GlobeNewswire) +82.35%
Jul-17-23 07:29AM	3 Doomed Biotech Stocks Destined for Disaster (InvestorPlace) +5.16%
Jun-23-23 05:00PM	Enochian BioSciences Inc. Announces Adjournment of 2023 Annual Stockholder Meeting (GlobeNewswire) -15.73%
Jun-08-23 08:45AM	Enochian BioSciences Announces that its Cancer Platform Remains on Track for Trials in Humans Following FDA Review (GlobeNewswire) -6.31%
Apr-03-23 09:00AM	Enochian BioSciences CEO Letter to Shareholders (GlobeNewswire) +10.37%
Mar-29-23 09:00AM	Enochian BioSciences Announces a Scientific Presentation of Proof-of-Concept Studies for a Potential Therapy for Cancers with a Poor Life Expectancy by a Leading Researcher (GlobeNewswire)
Mar-13-23 08:30AM	Enochian BioSciences Achieves Full Compliance with NASDAQ Filing Requirements (GlobeNewswire) +6.54%
Feb-23-23 04:04PM	Enochian BioSciences Announces Receipt of Notice from Nasdaq Regarding Delayed Filing of Form 10-Q for the Period Ended December 31, 2022 (GlobeNewswire) +19.77%
05:20PM	Loading…
Nov-30-22 05:20PM	Enochian BioSciences Announces Receipt of Notice from Nasdaq Regarding Delayed Filing of Form 10-Q for the Period Ended September 30, 2022 (GlobeNewswire)
Oct-26-22 12:01AM	Corrections & Amplifications (The Wall Street Journal) -8.04%
Oct-24-22 08:11PM	Biotech Co-Founder, Facing Murder-for-Hire Charges, Accused of Fabricating Data (The Wall Street Journal) -7.11%
08:00AM	Enochian BioSciences Forges Ahead With Focused Approach, Promising Future (GlobeNewswire)
Oct-21-22 05:00PM	Enochian BioSciences Announces Receipt of Notice from Nasdaq Regarding Delayed Filing of Annual Report on Form 10-K (GlobeNewswire)
Oct-17-22 08:30AM	Enochian BioSciences Awarded U.S. Patent For Its Promising Oncology Platform (GlobeNewswire) +7.34%
Sep-01-22 08:08AM	Enochian Biosciences, Inc. (NASDAQ:ENOB) insiders have significant skin in the game with 49% ownership (Simply Wall St.)
Jul-25-22 10:15AM	Enochian BioSciences Appoints Dr. Richard Whitley As Senior Scientific Advisor (GlobeNewswire) -10.50%
Jul-01-22 08:37PM	Enochian Biosciences Finds Falsified Data in Study of Covid-19 Treatment (The Wall Street Journal)
05:00PM	Enochian BioSciences Announces Findings From A Rigorous Internal Review of Scientific Data (GlobeNewswire)
Jun-27-22 03:00PM	Biotech Wizard Left a Trail of FraudProsecutors Allege It Ended in Murder (The Wall Street Journal) -21.92%
Jun-10-22 04:00PM	HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Enochian Biosciences (ENOB) Investors with Significant Losses to Contact Firms Attorneys, Firm Investigating Possible Securities Law Violations (ACCESSWIRE) +12.84%
Jun-09-22 05:59PM	Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Enochian To Contact Him Directly To Discuss Their Options (ACCESSWIRE) -5.10%
May-31-22 08:00AM	Scientific Leaders Agree on Promise of Enochian BioSciences (GlobeNewswire)
May-25-22 04:20PM	Enochian BioSciences Board Learns of Arrest of Co-Founder and Inventor and Expresses Strong Confidence in the Promising Future of the Company (GlobeNewswire) -36.97%
Apr-20-22 07:00AM	Enochian BioSciences Announces the Appointment of Executive Vice President of Research and Development with 25 years of Industry Experience (GlobeNewswire)
Apr-07-22 06:00AM	Enochian BioSciences Announces Appointment of Senior Vice President for Clinical Operations with 32 Years Experience at Pfizer (GlobeNewswire) -10.77%
Apr-06-22 09:07AM	Innovative Clinical Strategies to Treat HIV and Cancer Presented by Pioneering Research Scientist at the Innate Killer Summit in San Diego (PR Newswire)
Apr-05-22 06:00AM	Enochian BioSciences Inventor and Co-Founder Presents Data on Novel Clinical Approaches as the Invited, Concluding Plenary Speaker at the Innate Killer Summit (GlobeNewswire)
Mar-25-22 12:07PM	Is Enochian Biosciences, Inc. (NASDAQ:ENOB) Popular Amongst Insiders? (Simply Wall St.)
Mar-15-22 07:00AM	Enochian BioSciences and Caring Cross Announce a Partnership to Potentially Increase the Effectiveness of a CAR-T Approach for HIV Cure Currently Being Studied in Humans (GlobeNewswire)
Dec-03-21 07:00AM	Enochian BioSciences Announces Scientific Presentation at World Vaccine Conference on Promising Human and Laboratory Data to Potentially Treat Solid Tumors (GlobeNewswire) -18.64%
Oct-18-21 07:00AM	Enochian BioSciences Announces the Successful Completion of an FDA Pre-IND for a Potential Cure for HIV: The Second Pre-IND in 1 month (GlobeNewswire)
Oct-15-21 06:00PM	Scientific Advisory Board Member Resigns Due to Conflict with Responsibilities with Important Public Sector Entity (GlobeNewswire)
Oct-12-21 06:00PM	Fireside Chat with Enochian BioSciences CEO, Dr. Mark Dybul at H.C. Wainwright 2nd Annual Hepatitis B Virus (HBV) Conference (GlobeNewswire) +5.61%
Sep-27-21 07:00AM	Enochian BioSciences Announces Its Successful Completion of FDA Pre-IND for a Potential Cure for Hepatitis B Virus Infection (GlobeNewswire)
Sep-26-21 10:42AM	Is Enochian Biosciences (NASDAQ:ENOB) Using Debt In A Risky Way? (Simply Wall St.)
Sep-13-21 07:00AM	Enochian BioSciences to Present to Investors at the H.C. Wainwright 23rd Annual Investment Conference (GlobeNewswire)
Aug-30-21 07:00AM	Distinguished Scientific and Public Health Leaders to Join Enochian BioSciences Scientific Advisory Board for Potential Inhaled Treatment and Prevention of All COVID-19 and Influenza Variants (GlobeNewswire) +11.29%
Aug-23-21 10:18AM	Distinguished Scientific and Clinical Leader to Join Enochian BioSciences Hepatitis B Cure Scientific Advisory Board (GlobeNewswire) +6.07%
Jul-20-21 07:00AM	Enochian BioSciences Names The Hon. Dr. Mark Dybul as Chief Executive Officer (GlobeNewswire)
Jul-12-21 08:37AM	Enochian Stock Is Trading Higher On FDA Acceptance of Pre-IND Request For Hepatitis B Program (Benzinga)
07:00AM	Enochian BioSciences Announces FDA Acceptance of Pre-IND Request For Potential Cure for Hepatitis B Virus Infection (GlobeNewswire)
05:37AM	Enochian Gains As FDA Agrees To Give View On Potential Cure For Hepatitis B (Investing.com)
Jun-30-21 07:00AM	Enochian BioSciences Announces Scientific Presentation of Elimination of HBV in Mice with No Evident Toxicity (GlobeNewswire)
Jun-21-21 05:31PM	Why Enochian BioSciences Was a Winner on Monday (Motley Fool)
08:03AM	Enochian BioSciences Stock Is Trading Higher After In-Licensing COVID-19, Influenza Inhaled Treatment Technology (Benzinga)
07:00AM	Enochian BioSciences Announces Acquisition of Exclusive License for Potential Pan-Coronavirus and Pan-Influenza Inhaled Treatment and Prevention Technology (GlobeNewswire)
Jun-15-21 09:05AM	Pioneering Research Institute In Los Angeles Moves One Step Closer To Finding A Cure For HIV (PR Newswire) -12.52%
Jun-14-21 03:15PM	Here's Why Enochian BioSciences Stock Skyrocketed Today (Motley Fool) +53.97%
02:53PM	Enochian BioSciences Announces $29 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules (GlobeNewswire)
08:42AM	Mondays Pre-Market: Heres What You Need to Know Before the Market Opens (TipRanks)
07:00AM	Enochian BioSciences Announces FDA Acceptance of Pre-IND Request For Potential HIV Cure (GlobeNewswire)
May-12-21 04:29PM	Enochian BioSciences announces Scientific Presentation of a Person with HIV Exhibiting Controlled Blood Levels of Virus for 255 Days Following Treatment with a Novel Cellular Therapy (GlobeNewswire)
08:05AM	A Promising Approach To HIV Cell Therapy, With Exciting Preliminary Results, Was Presented Recently At The Leading Conference On Gene And Cell Therapy (PR Newswire)
Apr-30-21 03:42AM	Is Enochian Biosciences, Inc.'s (NASDAQ:ENOB) Shareholder Ownership Skewed Towards Insiders? (Simply Wall St.)
Mar-24-21 06:00PM	Seraph Research Institute and Enochian BioSciences Publish a Case Report of Complete Remission of Recurrent Glioblastoma with Innovative Therapy (GlobeNewswire) -7.65%
Feb-22-21 05:15PM	Enochian BioSciences to Present to Investors at the H.C. Wainwright Global Life Sciences Conference (GlobeNewswire) -9.32%
Nov-01-20 09:35AM	What You Need To Know About Enochian Biosciences, Inc.'s (NASDAQ:ENOB) Investor Composition (Simply Wall St.)
Sep-10-20 12:50AM	Enochian BioSciences to Present to Investors at 22nd Annual H.C. Wainwright Global Investment Conference (GlobeNewswire)
Jul-27-20 08:00AM	Distinguished Scientific Leaders to Join Enochian BioSciences Hepatitis B Scientific Advisory Board (GlobeNewswire)
Jun-08-20 07:30AM	Enochian BioSciences Announces Its Successful Completion of FDA INTERACT Meeting for a Potential Cure for HIV (GlobeNewswire) +47.09%
May-14-20 09:50AM	Company News for May 14, 2020 (Zacks) -10.12%
May-13-20 08:00AM	Enochian Biosciences Announces Three Scientific Presentations on Potential HIV and HBV Cures (GlobeNewswire) +38.89%
Apr-23-20 07:00AM	Is Enochian Biosciences (NASDAQ:ENOB) In A Good Position To Deliver On Growth Plans? (Simply Wall St.) -5.16%
Apr-09-20 10:00AM	Enochian Biosciences Announces Scientific Presentations at the American Society of Cell and Gene Therapy (ASCGT) Annual Meeting (GlobeNewswire)
Feb-24-20 07:30AM	Enochian Biosciences Announces FDA INTERACT Meeting for a Potential Cure for HIV (GlobeNewswire)
Feb-03-20 07:30AM	Enochian Biosciences Acquires an Exclusive License for a Novel Hepatitis B Virus Potential Treatment or Cure (GlobeNewswire) +6.09%
Jan-06-20 07:30AM	Enochian Biosciences, a company focused on gene-modified cellular therapy in infectious disease and cancer, announces the appointment of two board members: (GlobeNewswire) -11.63%
Dec-10-19 07:00AM	Enochian Biosciences Announces Scientific Presentation of a Novel Approach to Potentially Cure Hepatitis B Virus (GlobeNewswire)
Nov-25-19 07:00AM	Enochian Biosciences Expands its Infectious Disease Pipeline by Entering into an Agreement in Principle to Acquire an Exclusive License for a Novel Hepatitis B Virus Treatment (GlobeNewswire) +14.91%
Nov-21-19 10:30AM	Enochain Investor Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Enochain Biosciences Inc. To Contact The Firm (Newsfile)
Oct-31-19 04:17PM	Penny Stocks to Buy Using Technical Analysis for November 2019 (Investopedia)
Oct-26-19 10:18AM	We're Not Very Worried About Enochian Biosciences's (NASDAQ:ENOB) Cash Burn Rate (Simply Wall St.)
Jun-03-19 07:00AM	Enochian BioSciences Inventor Named to Two Important Scientific Committees (GlobeNewswire)
Apr-29-19 09:19AM	Enochian Biosciences (NASDAQ:ENOB) Shareholders Have Enjoyed A 37% Share Price Gain (Simply Wall St.) -8.15%
Mar-07-19 12:45PM	Successful Treatment of London Patient Underscores Clinical Potential of Enochian Biosciences Gene Modified Cellular Therapy for HIV (GlobeNewswire) -6.88%
Feb-01-19 02:31PM	4 Healthcare Stocks Looking To Start February Off Strong (ACCESSWIRE) +9.88%
Jan-16-19 04:00PM	OTC Markets Group Announces Quarterly Index Performance and Rebalancing (PR Newswire) +10.00%
Jan-07-19 08:30AM	Enochian Biosciences Announces Appointment of Dr. Mark Dybul as Executive Vice-Chair (GlobeNewswire)

Renovaro Biosciences, Inc. is a pre-clinical stage biotechnology company, which engages in the development of genetically modified cellular and immune-therapy technologies used for the treatment of infectious diseases and cancer. Its pipeline consists of ENOB-HV-01, ENOB- HV-11, ENOB-HV-12, ENOB-DB-01, ENOB-DC-01, ENOB-DC-11, and ENOB-DC-21. The company was founded by Rene Sindlev and Serhat Gumrukcu on January 18, 2011 and is headquartered in Los Angeles, CA.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

RENB

Renovaro Biosciences Inc

Upgrade your FINVIZ experience